138 related articles for article (PubMed ID: 2997819)
1. The effects of thyrotropin releasing hormone on rats with lesions of the mesolimbic and nigrostriatal dopamine systems.
Andrews JS; Sahgal A
Physiol Behav; 1985 Jul; 35(1):93-7. PubMed ID: 2997819
[TBL] [Abstract][Full Text] [Related]
2. The relationship between striatal and mesolimbic dopamine dysfunction and the nature of circling responses following 6-hydroxydopamine and electrolytic lesions of the ascending dopamine systems of rat brain.
Costall B; Marsden CD; Naylor RJ; Pycock CJ
Brain Res; 1976 Dec; 118(1):87-113. PubMed ID: 990957
[TBL] [Abstract][Full Text] [Related]
3. Neuroleptic-like disruption of the conditioned avoidance response requires destruction of both the mesolimbic and nigrostriatal dopamine systems.
Koob GF; Simon H; Herman JP; Le Moal M
Brain Res; 1984 Jun; 303(2):319-29. PubMed ID: 6430466
[TBL] [Abstract][Full Text] [Related]
4. Pharmacological study of TA-0910, a new thyrotropin-releasing hormone (TRH) analog (II): Involvement of the DA system in the locomotor stimulating action of TA-0910.
Yamamura M; Kinoshita K; Nakagawa H; Ishida R
Jpn J Pharmacol; 1991 Jan; 55(1):57-68. PubMed ID: 1904114
[TBL] [Abstract][Full Text] [Related]
5. Modification of dopaminergic transmission by thyrotropin-releasing hormone.
Narumi S; Nagawa Y
Adv Biochem Psychopharmacol; 1983; 36():185-97. PubMed ID: 6305147
[TBL] [Abstract][Full Text] [Related]
6. [Thyrotropin-releasing hormone (TRH): Enhancement of dopamine dependent circling behavior and its own circling-inducing effect in unilateral striatal lesioned animals (author's transl)].
Fukuda N; Miyamoto M; Narumi S; Nagai Y; Shima T; Nagawa Y
Nihon Yakurigaku Zasshi; 1979 Apr; 75(3):251-70. PubMed ID: 231554
[TBL] [Abstract][Full Text] [Related]
7. Central administration of thyrotropin-releasing hormone and histidyl-proline-diketopiperazine disrupts the acquisition of a food rewarded task by a non-aversive action.
Andrews JS; Sahgal A
Regul Pept; 1983 Dec; 7(4):373-83. PubMed ID: 6422515
[TBL] [Abstract][Full Text] [Related]
8. Effects of behaviorally active doses of thyrotropin-releasing hormone and its analog MK-771 on dopaminergic neuronal systems in the brain of the rat.
Yamada K; Demarest KT; Moore KE
Neuropharmacology; 1984 Jul; 23(7A):735-9. PubMed ID: 6433220
[TBL] [Abstract][Full Text] [Related]
9. The effects of thyrotropin releasing hormone on a visual discrimination task in rats.
Andrews JS; Sahgal A
Pharmacol Biochem Behav; 1984 Nov; 21(5):715-9. PubMed ID: 6440155
[TBL] [Abstract][Full Text] [Related]
10. A possible mechanism of action of thyrotropin-releasing hormone (TRH) and its analog DN-1417 on the release of dopamine from the nucleus accumbens and striatum in rats.
Narumi S; Nagai Y; Saji Y; Nagawa Y
Jpn J Pharmacol; 1985 Dec; 39(4):425-35. PubMed ID: 2869169
[TBL] [Abstract][Full Text] [Related]
11. Actions of substance P, MIF, TRH and related peptides in the substantia nigra, caudate nucleus and nucleus accumbens.
Pinnock RD; Woodruff GN; Turnbull MJ
Neuropharmacology; 1983 Jun; 22(6):687-96. PubMed ID: 6193454
[TBL] [Abstract][Full Text] [Related]
12. Mesolimbic involvement in the locomotor stimulant action of thyrotropin-releasing hormone (TRH) in rats.
Miyamoto M; Nagawa Y
Eur J Pharmacol; 1977 Jul; 44(2):143-52. PubMed ID: 407089
[TBL] [Abstract][Full Text] [Related]
13. Interaction between thyrotropin-releasing hormone and the mesolimbic dopamine system.
Kalivas PW; Stanley D; Prange AJ
Neuropharmacology; 1987 Jan; 26(1):33-8. PubMed ID: 3104814
[TBL] [Abstract][Full Text] [Related]
14. In vivo electrochemical and behavioral evidence for specific neural substrates modulated differentially by enkephalin in rat stimulant stereotypy and locomotion.
Broderick PA; Gardner EL; van Praag HM
Biol Psychiatry; 1984 Jan; 19(1):45-54. PubMed ID: 6538442
[TBL] [Abstract][Full Text] [Related]
15. Amphetamine-induced rotation reveals post 6-OHDA lesion neurochemical reorganization.
Lynch MR; Carey RJ
Behav Brain Res; 1989 Feb; 32(1):69-74. PubMed ID: 2495013
[TBL] [Abstract][Full Text] [Related]
16. Modifications of mesolimbic and nigrostriatal dopaminergic activities after intracerebroventricular administration of prolactin.
Hernández ML; Fernández-Ruiz JJ; Navarro M; de Miguel R; Cebeira M; Vaticón L; Ramos JA
J Neural Transm Gen Sect; 1994; 96(1):63-79. PubMed ID: 7857592
[TBL] [Abstract][Full Text] [Related]
17. Selective activation of mesolimbic and mesocortical dopamine metabolism in rat brain by infusion of a stable substance P analogue into the ventral tegmental area.
Elliott PJ; Alpert JE; Bannon MJ; Iversen SD
Brain Res; 1986 Jan; 363(1):145-7. PubMed ID: 2418910
[TBL] [Abstract][Full Text] [Related]
18. Effects of B-HT 920 on nigrostriatal and mesolimbic dopamine systems in normosensitive and supersensitive rats.
Clarke PB; Wyder KJ; Jakubovic A; Fibiger HC
Br J Pharmacol; 1990 Mar; 99(3):509-15. PubMed ID: 2110017
[TBL] [Abstract][Full Text] [Related]
19. The involvement of central cholinergic mechanisms in cardiovascular responses to intracerebroventricular and intravenous administration of thyrotropin-releasing hormone.
Okuda C; Mizobe T; Miyazaki M
Life Sci; 1987 Mar; 40(13):1293-9. PubMed ID: 3104710
[TBL] [Abstract][Full Text] [Related]
20. In vivo evaluation by differential pulse voltammetry of the effect of thyrotropin-releasing hormone (TRH) on dopaminergic and serotoninergic synaptic activity in the striatum and nucleus accumbens of the rat.
Crespi F; Keane PE; Morre M
Exp Brain Res; 1986; 62(2):329-34. PubMed ID: 2423357
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]